-
Analyst Opinions
Biocomputing: Market Trends and Innovations
Biocomputing is transitioning from a research-led concept into a deployable computing paradigm, where computation is executed through molecular and cellular processes rather than electronic circuits. The latest Innovation Radar: Biocomputing report examines how biology is being engineered as a programmable execution layer, capable of storing information, processing logic, and generating outputs directly within biological environments. At the core of this shift is a maturing biocomputing stack that integrates biological substrates with digital infrastructure. Computation is encoded in DNA, RNA, proteins,...
-
Thematic Analysis
Genomics: FutureTech Series
Genomic innovation is accelerating the transition to faster diagnostics, scalable biomanufacturing, and precision therapies. GlobalData’s latest FutureTech Series: Genomics report delivers a comprehensive analysis of the technologies redefining molecular healthcare. The report highlights automated DNA extraction, metagenomic pathogen detection, genome-edited iPSC therapies, plasmid DNA extraction kits, and isothermal DNA amplification, each positioned to address critical challenges in clinical reliability, decentralized testing, and therapeutic accessibility. Using GlobalData’s proprietary Tech Foresights platform, the report examines innovation drivers, challenges, patent leadership, and real-world...
-
Sector Analysis
Clinical Trials: Biomarkers to Support Clinical Endpoints
This report provides a comprehensive analysis of biomarkers in clinical trials. The purpose of this report is to offer valuable insights into the landscape of clinical trials involving biomarkers by highlighting trends and patterns across various dimensions. Ultimately, this report serves as a resource for researchers, clinicians, and industry stakeholders seeking to understand the evolving role of biomarkers in clinical trials. The insights derived from this analysis can inform future research directions, enhance trial design, and contribute to feasibility planning. This...
-
Sector Analysis
Cell Therapy for Autoimmune Diseases - Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals
Cell therapy for autoimmune diseases involves using various types of cells, such as mesenchymal stem cells or regulatory T cells, to modulate the immune system and reduce inflammation in patients with autoimmune disorders. These cells are often derived from the patient's own body or from a donor and are administered through injections or infusions. The goal of cell therapy is to restore immune balance and tolerance, ultimately leading to a reduction in disease symptoms and progression. While still in the...
-
Product Insights
Adoptive Cell Therapy - Clinical Trials Overview and Analysis
This report provides an overview of Adoptive Cell Therapy clinical trials captured in the GlobalData Pharma Intelligence Center until May 1, 2024. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively. As the number of Adoptive Cell Therapy clinical trials continues to increase, a deeper understanding of these trials, such as sponsor type, therapy areas, location, and phase, are...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.